Category: us corporate news

us corporate news

Rayonier Inc. 8-K Filing March 2026: Change in Certifying Accountant, Company Details & XBRL Data

Minichart

March 18, 2026

Rayonier Inc. Announces Change in Independent Auditor: Ernst...

Continue Reading 0

us corporate news

Enzon Pharmaceuticals 8-K Filing Details Tenth Amendment to Rights Agreement – Company Information and SEC Compliance

Minichart

March 18, 2026

Enzon Pharmaceuticals, Inc. Announces Tenth Amendment to Sec...

Continue Reading 0

us corporate news

Gain Therapeutics Presents Positive Phase 1b Results for GT-02287 in Parkinson’s Disease and Advances New GCase Modulators for Clinical Development 123

Minichart

March 18, 2026

Gain Therapeutics Reports Positive Phase 1b Results for GT-0...

Continue Reading 0

us corporate news

SRx Health Solutions Announces $8 Million Private Placement of Series B Convertible Preferred Stock and Warrants

Minichart

March 18, 2026

SRX Health Solutions Inc. Announces Private Placement of Ser...

Continue Reading 0

us corporate news

Off The Hook Yachts Expands in Chesapeake Bay with New Waterfront Hub to Boost Inventory and Efficiency 1

Minichart

March 18, 2026

Off The Hook Yachts Expands Mid-Atlantic Operations with Str...

Continue Reading 0

us corporate news

Mosaic Co 2025 Amended Annual Report (10-K/A): Key Filings, Certifications, and Company Details

Minichart

March 18, 2026

The Mosaic Company Files Amendment No. 1 to 2025 Annual Repo...

Continue Reading 0

us corporate news

Longeveron Inc. 2026 10-K: Clinical-Stage Biotech Advancing Laromestrocel (Lomecel-B) for Regenerative Medicine and Intellectual Property Expansion

Minichart

March 18, 2026

Longeveron Inc. Annual Report (FY2025): Key Highlights for I...

Continue Reading 0

us corporate news

Academy Sports + Outdoors 2026 Company Overview: Business Strategy, Merchandising, Omnichannel Growth, and Risk Factors

Minichart

March 18, 2026

Academy Sports & Outdoors, Inc. FY2025 10-K – Key Takeaways ...

Continue Reading 0

us corporate news

Gossamer Bio 2025 Annual Report: Seralutinib PAH Clinical Development, FDA Path, and Regulatory Strategy Insights

Minichart

March 18, 2026

Gossamer Bio, Inc. 2025 Annual Report: Key Highlights for In...

Continue Reading 0

us corporate news

AN2 Therapeutics 2025 Annual Report: Business Overview, Pipeline, Strategy, and Regulatory Insights

Minichart

March 18, 2026

AN2 Therapeutics (ANTX) 2025 Annual Report – Key Highlights ...

Continue Reading 0